Selected research
Industry Research
IVD Reagent Clinical Trial Services Industry Research Report 2026
Market perspective
The global IVD Reagent Clinical Trial Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the IVD Reagent Clinical Trial Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the IVD Reagent Clinical Trial Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the IVD Reagent Clinical Trial Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of IVD Reagent Clinical Trial Services include IQVIA, ICON plc, Labcorp, NAMSA, Parexel, Medpace, Fortrea, Quest Diagnostics and Avania, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global IVD Reagent Clinical Trial Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to IVD Reagent Clinical Trial Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
IVD Reagent Clinical Trial Services Market by Company
IQVIA
ICON plc
Labcorp
NAMSA
Parexel
Medpace
Fortrea
Quest Diagnostics
Avania
Hangzhou Tigermed Consulting
Eurofins Scientific
Cerba Research
ClinChoice
CMIC Group
Syneos Health
ResearchDx
Premier Research
Quanticate
SGS
Guangzhou Jinmanli Pharmaceutical Technology
WuXi AppTec
IVD Reagent Clinical Trial Services Segment by Type
Early-Stage Clinical Trials (Phase I)
Late-Stage Clinical Trials (Phase III)
IVD Reagent Clinical Trial Services Segment by Application
Early Cancer Screening
Infectious Disease Testing
Genetic Disease Diagnosis
Other
IVD Reagent Clinical Trial Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IVD Reagent Clinical Trial Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of IVD Reagent Clinical Trial Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IVD Reagent Clinical Trial Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of IVD Reagent Clinical Trial Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Early-Stage Clinical Trials (Phase I)
- Late-Stage Clinical Trials (Phase III)
Applications
- Early Cancer Screening
- Infectious Disease Testing
- Genetic Disease Diagnosis
- Other
Companies covered
- IQVIA
- ICON plc
- Labcorp
- NAMSA
- Parexel
- Medpace
- Fortrea
- Quest Diagnostics
- Avania
- Hangzhou Tigermed Consulting
- Eurofins Scientific
- Cerba Research
- ClinChoice
- CMIC Group
- Syneos Health
- ResearchDx
- Premier Research
- Quanticate
- SGS
- Guangzhou Jinmanli Pharmaceutical Technology
- WuXi AppTec
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 IVD Reagent Clinical Trial Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Early-Stage Clinical Trials (Phase I)
- 2.2.3 Late-Stage Clinical Trials (Phase III)
- 2.3 IVD Reagent Clinical Trial Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Early Cancer Screening
- 2.3.3 Infectious Disease Testing
- 2.3.4 Genetic Disease Diagnosis
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 IVD Reagent Clinical Trial Services Breakdown Data by Type
- 3.1 Global IVD Reagent Clinical Trial Services Historic Market Size by Type (2021-2026)
- 3.2 Global IVD Reagent Clinical Trial Services Forecasted Market Size by Type (2027-2032)
4 IVD Reagent Clinical Trial Services Breakdown Data by Application
- 4.1 Global IVD Reagent Clinical Trial Services Historic Market Size by Application (2021-2026)
- 4.2 Global IVD Reagent Clinical Trial Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global IVD Reagent Clinical Trial Services Market Perspective (2021-2032)
- 5.2 Global IVD Reagent Clinical Trial Services Growth Trends by Region
- 5.2.1 Global IVD Reagent Clinical Trial Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 IVD Reagent Clinical Trial Services Historic Market Size by Region (2021-2026)
- 5.2.3 IVD Reagent Clinical Trial Services Forecasted Market Size by Region (2027-2032)
- 5.3 IVD Reagent Clinical Trial Services Market Dynamics
- 5.3.1 IVD Reagent Clinical Trial Services Industry Trends
- 5.3.2 IVD Reagent Clinical Trial Services Market Drivers
- 5.3.3 IVD Reagent Clinical Trial Services Market Challenges
- 5.3.4 IVD Reagent Clinical Trial Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top IVD Reagent Clinical Trial Services Players by Revenue
- 6.1.1 Global Top IVD Reagent Clinical Trial Services Players by Revenue (2021-2026)
- 6.1.2 Global IVD Reagent Clinical Trial Services Revenue Market Share by Players (2021-2026)
- 6.2 Global IVD Reagent Clinical Trial Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of IVD Reagent Clinical Trial Services Head Office and Area Served
- 6.4 Global IVD Reagent Clinical Trial Services Players, Product Type & Application
- 6.5 Global IVD Reagent Clinical Trial Services Manufacturers Established Date
- 6.6 Global IVD Reagent Clinical Trial Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America IVD Reagent Clinical Trial Services Market Size (2021-2032)
- 7.2 North America IVD Reagent Clinical Trial Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America IVD Reagent Clinical Trial Services Market Size by Country (2021-2026)
- 7.4 North America IVD Reagent Clinical Trial Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe IVD Reagent Clinical Trial Services Market Size (2021-2032)
- 8.2 Europe IVD Reagent Clinical Trial Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe IVD Reagent Clinical Trial Services Market Size by Country (2021-2026)
- 8.4 Europe IVD Reagent Clinical Trial Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific IVD Reagent Clinical Trial Services Market Size (2021-2032)
- 9.2 Asia-Pacific IVD Reagent Clinical Trial Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific IVD Reagent Clinical Trial Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific IVD Reagent Clinical Trial Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America IVD Reagent Clinical Trial Services Market Size (2021-2032)
- 10.2 South America IVD Reagent Clinical Trial Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America IVD Reagent Clinical Trial Services Market Size by Country (2021-2026)
- 10.4 South America IVD Reagent Clinical Trial Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa IVD Reagent Clinical Trial Services Market Size (2021-2032)
- 11.2 Middle East & Africa IVD Reagent Clinical Trial Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa IVD Reagent Clinical Trial Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa IVD Reagent Clinical Trial Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 IQVIA
- 12.1.1 IQVIA Company Information
- 12.1.2 IQVIA Business Overview
- 12.1.3 IQVIA Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.1.4 IQVIA IVD Reagent Clinical Trial Services Product Portfolio
- 12.1.5 IQVIA Recent Developments
- 12.2 ICON plc
- 12.2.1 ICON plc Company Information
- 12.2.2 ICON plc Business Overview
- 12.2.3 ICON plc Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.2.4 ICON plc IVD Reagent Clinical Trial Services Product Portfolio
- 12.2.5 ICON plc Recent Developments
- 12.3 Labcorp
- 12.3.1 Labcorp Company Information
- 12.3.2 Labcorp Business Overview
- 12.3.3 Labcorp Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.3.4 Labcorp IVD Reagent Clinical Trial Services Product Portfolio
- 12.3.5 Labcorp Recent Developments
- 12.4 NAMSA
- 12.4.1 NAMSA Company Information
- 12.4.2 NAMSA Business Overview
- 12.4.3 NAMSA Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.4.4 NAMSA IVD Reagent Clinical Trial Services Product Portfolio
- 12.4.5 NAMSA Recent Developments
- 12.5 Parexel
- 12.5.1 Parexel Company Information
- 12.5.2 Parexel Business Overview
- 12.5.3 Parexel Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.5.4 Parexel IVD Reagent Clinical Trial Services Product Portfolio
- 12.5.5 Parexel Recent Developments
- 12.6 Medpace
- 12.6.1 Medpace Company Information
- 12.6.2 Medpace Business Overview
- 12.6.3 Medpace Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.6.4 Medpace IVD Reagent Clinical Trial Services Product Portfolio
- 12.6.5 Medpace Recent Developments
- 12.7 Fortrea
- 12.7.1 Fortrea Company Information
- 12.7.2 Fortrea Business Overview
- 12.7.3 Fortrea Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.7.4 Fortrea IVD Reagent Clinical Trial Services Product Portfolio
- 12.7.5 Fortrea Recent Developments
- 12.8 Quest Diagnostics
- 12.8.1 Quest Diagnostics Company Information
- 12.8.2 Quest Diagnostics Business Overview
- 12.8.3 Quest Diagnostics Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.8.4 Quest Diagnostics IVD Reagent Clinical Trial Services Product Portfolio
- 12.8.5 Quest Diagnostics Recent Developments
- 12.9 Avania
- 12.9.1 Avania Company Information
- 12.9.2 Avania Business Overview
- 12.9.3 Avania Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.9.4 Avania IVD Reagent Clinical Trial Services Product Portfolio
- 12.9.5 Avania Recent Developments
- 12.10 Hangzhou Tigermed Consulting
- 12.10.1 Hangzhou Tigermed Consulting Company Information
- 12.10.2 Hangzhou Tigermed Consulting Business Overview
- 12.10.3 Hangzhou Tigermed Consulting Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.10.4 Hangzhou Tigermed Consulting IVD Reagent Clinical Trial Services Product Portfolio
- 12.10.5 Hangzhou Tigermed Consulting Recent Developments
- 12.11 Eurofins Scientific
- 12.11.1 Eurofins Scientific Company Information
- 12.11.2 Eurofins Scientific Business Overview
- 12.11.3 Eurofins Scientific Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.11.4 Eurofins Scientific IVD Reagent Clinical Trial Services Product Portfolio
- 12.11.5 Eurofins Scientific Recent Developments
- 12.12 Cerba Research
- 12.12.1 Cerba Research Company Information
- 12.12.2 Cerba Research Business Overview
- 12.12.3 Cerba Research Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.12.4 Cerba Research IVD Reagent Clinical Trial Services Product Portfolio
- 12.12.5 Cerba Research Recent Developments
- 12.13 ClinChoice
- 12.13.1 ClinChoice Company Information
- 12.13.2 ClinChoice Business Overview
- 12.13.3 ClinChoice Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.13.4 ClinChoice IVD Reagent Clinical Trial Services Product Portfolio
- 12.13.5 ClinChoice Recent Developments
- 12.14 CMIC Group
- 12.14.1 CMIC Group Company Information
- 12.14.2 CMIC Group Business Overview
- 12.14.3 CMIC Group Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.14.4 CMIC Group IVD Reagent Clinical Trial Services Product Portfolio
- 12.14.5 CMIC Group Recent Developments
- 12.15 Syneos Health
- 12.15.1 Syneos Health Company Information
- 12.15.2 Syneos Health Business Overview
- 12.15.3 Syneos Health Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.15.4 Syneos Health IVD Reagent Clinical Trial Services Product Portfolio
- 12.15.5 Syneos Health Recent Developments
- 12.16 ResearchDx
- 12.16.1 ResearchDx Company Information
- 12.16.2 ResearchDx Business Overview
- 12.16.3 ResearchDx Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.16.4 ResearchDx IVD Reagent Clinical Trial Services Product Portfolio
- 12.16.5 ResearchDx Recent Developments
- 12.17 Premier Research
- 12.17.1 Premier Research Company Information
- 12.17.2 Premier Research Business Overview
- 12.17.3 Premier Research Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.17.4 Premier Research IVD Reagent Clinical Trial Services Product Portfolio
- 12.17.5 Premier Research Recent Developments
- 12.18 Quanticate
- 12.18.1 Quanticate Company Information
- 12.18.2 Quanticate Business Overview
- 12.18.3 Quanticate Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.18.4 Quanticate IVD Reagent Clinical Trial Services Product Portfolio
- 12.18.5 Quanticate Recent Developments
- 12.19 SGS
- 12.19.1 SGS Company Information
- 12.19.2 SGS Business Overview
- 12.19.3 SGS Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.19.4 SGS IVD Reagent Clinical Trial Services Product Portfolio
- 12.19.5 SGS Recent Developments
- 12.20 Guangzhou Jinmanli Pharmaceutical Technology
- 12.20.1 Guangzhou Jinmanli Pharmaceutical Technology Company Information
- 12.20.2 Guangzhou Jinmanli Pharmaceutical Technology Business Overview
- 12.20.3 Guangzhou Jinmanli Pharmaceutical Technology Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.20.4 Guangzhou Jinmanli Pharmaceutical Technology IVD Reagent Clinical Trial Services Product Portfolio
- 12.20.5 Guangzhou Jinmanli Pharmaceutical Technology Recent Developments
- 12.21 WuXi AppTec
- 12.21.1 WuXi AppTec Company Information
- 12.21.2 WuXi AppTec Business Overview
- 12.21.3 WuXi AppTec Revenue in IVD Reagent Clinical Trial Services Business (2021-2026)
- 12.21.4 WuXi AppTec IVD Reagent Clinical Trial Services Product Portfolio
- 12.21.5 WuXi AppTec Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst